Lisa joined Simcyp in 2005, bringing her expertise in predicting pharmacokinetics (PK) and drug-drug interactions (DDIs) while integrating drug and population models within the Simcyp Simulator. Over the past decade, she has been instrumental in helping clients navigate complex drug development challenges with customized PBPK modeling solutions.

With a strong background in infectious diseases, Lisa leads Global Health projects and is committed to advancing PBPK applications for understudied and complex populations, including pregnant and breastfeeding women. Her work focuses on addressing gaps in clinical data, improving drug treatment strategies, and supporting the inclusion of diverse populations in clinical research. She also serves as an Executive Editor for the British Journal of Clinical Pharmacology.

Lisa is known for her collaborative approach and practical, science-driven perspective. She works closely with pharmaceutical and biotech teams on regulatory strategy, DDI assessment, and PBPK applications, including for special populations. Her experience supports informed decision-making across drug development programs.